Joint committee on the Human Tissue and Embryos (Draft) Bill First Report


APPENDIX 7: MEMORANDUM ON BEHALF OF THE CHAIRMAN OF THE HOUSE OF LORDS SELECT COMMITTEE ON DELEGATED POWERS AND REGULATORY REFORM


1.  This memorandum responds to your invitation of 5 June to the Delegated Powers Committee to contribute to your Committee's scrutiny of the draft Human Tissue and Embryos Bill. The Committee considered the draft bill at its meeting this morning and I am replying to you in Lord Goodhart's absence abroad.

2.  We value the opportunity to contribute to the pre-legislative scrutiny of this draft bill and set out below an overview of our opinion on the proposed delegations. In making these observations, our opinion should not however be taken to prejudge our position should a bill be introduced: we will report to the House at that stage on whether its provisions inappropriately delegate legislative power or whether they subject the exercise of legislative power to an inappropriate degree of parliamentary scrutiny. I should also note that we have considered each issue purely as a question of delegation: this draft bill raises difficult issues of policy and the Joint Committee may well wish to recommend, on policy grounds, that it is inappropriate to delegate certain other matter in the draft bill. We have been assisted by a memorandum by the Department of Health about the significant delegations in the bill.

General

3.  There is nothing in the delegations in this draft bill which is not precedented in other areas. What is unusual is the number of powers subject to affirmative procedure: but this is appropriate due to the subject-matter. We also note that the 1990 Act, which Part 2 of the draft bill would amend, contains more detail than is usually found in Acts dealing with other licensing schemes, where more tends to be left to delegated legislation. This reflects that the 1990 Act covered new ground and the sensitivity of the subject-matter. Unless Parliament considers that there has been a significant reduction in public concern about the matters regulated by the 1990 Act, it is appropriate for the pattern of that Act to be repeated in the new legislation. We also note however the extent to which this area is regulated by the European Union and so subject to secondary legislation under the European Communities Act 1972.

Definitions—clause 14(5)

4.  Section 1 of the 1990 Act defines "embryo", "eggs", "sperm" and "gametes". These expressions are central to the Act: for example, the basic prohibitions in sections 3 and 4 are framed in terms of embryos or gametes, e.g. the prohibition on keeping or using an embryo without a licence. Clause 14(1) to (4) of the draft bill amends the definitions. In addition, clause 14(5) gives power to the Secretary of State, by regulations subject to affirmative procedure, to expand (but not contract) the definitions. This, and the associated restrictions on the power, are explained at paragraphs 25 and 26 of the memorandum.

5.  The use of an affirmative procedure order to bring additional matters within the scope of an Act is well established. Since the power in this case may be used only in the light of developments in science or medicine, and cannot be used to apply the Act to items which could not reasonably be described as embryos, eggs, sperm or gametes, we do not consider the approach inappropriate.

Permitted eggs and embryos—clause 16(5)

6.  Section 3(2) of the 1990 Act (as amended by clause 16(2) of the draft bill) prohibits placing in a woman an embryo other than a permitted embryo, and gametes other than permitted eggs or permitted sperm. Permitted embryos, eggs and sperm are defined in new section 3ZA, inserted by clause 16(5). New section 3ZA(5) enables the Secretary of State (by regulations subject to affirmative procedure) to provide that "permitted egg" and "permitted embryo" can include an egg or embryo which has undergone a process to prevent transmission of serious mitochondrial disease. This is explained at paragraphs 53 and 54 of the Explanatory Notes; and paragraph 30 of the memorandum explains that the resulting eggs or embryos would have a genetic contribution from 3 individuals.

7.  As a delegation, the power is well circumscribed with a clear principle. The extension might have serious and complicated knock-on effects (see clause 34 and paragraph 11 below), but the extent of the extension is apparent from the bill itself and can be debated and amended if this draft were introduced as a bill. Although we would not have difficulty with the delegation, there may be policy reasons for excluding the provision from the bill, regardless of whether or not the extension is in the bill itself or delegated to the Secretary of State.

Research licences: inter-species embryo etc.—Schedule 2, paragraph 6 and clause 23

8.  Clause 17(2) (new section 4A(2) of the 1990 Act) prohibits mixing human and animal gametes or creating, keeping or using an inter-species embryo without a licence. Schedule 2 to the 1990 Act, as amended by the draft bill, sets out in detail the specific activities (in connection with treatment, non-medical fertility services, storage and research licences) which may be licensed. To reflect clause 17(2), new paragraph 3(3) of Schedule 2 to the 1990 Act, inserted by paragraph 6 of Schedule 2 to the bill, enables the Secretary of State, by regulations subject to affirmative procedure, to authorise activities falling within new section 4A(2) of the 1990 Act.

9.  In contrast, paragraph 3(1) of Schedule 2 to the 1990 Act is specific about the activities which may be licensed in connection with human embryos. If a bill were introduced containing provision similar to paragraph 6 of Schedule 2 in the draft bill, we would require a more convincing explanation than that provided in paragraphs 33 to 36 of the memorandum as to why the bill itself cannot specify which activities the regulations may authorise for inter-species embryos. A similar point arises on clause 23 (paragraphs 37 and 38 of the memorandum).

Licensing procedures etc.—clauses 27 and 28

10.  The Regulatory Authority for Tissue and Embryos (RATE) is empowered by the draft bill to prescribe its own procedures for licensing and reconsideration of decisions. In other regulatory contexts, this is sometimes done by the Secretary of State by regulations subject to a parliamentary procedure, but empowering a regulatory body to set its own procedures is not an inappropriate or unprecedented way to proceed. The Joint Committee should note however that, if this latter model is chosen, Parliament cannot expect to retain powers of scrutiny over the procedures.

Mitochondrial donation—clause 34

11.  Clause 34 is explained at paragraphs 56 and 57 of the memorandum and paragraphs 149 and 150 of the Explanatory Notes. The power (subject to affirmative procedure) is to modify specific provisions of the 1990 Act in relation to particular circumstances specified in the bill (an egg or embryo created from material provided by two women). The scope of the delegation is not inappropriate, but the exercise of the power would raise difficult issues, some of which are identified at paragraph 57 of the memorandum. These issues justify the affirmative procedure provided, but we do not accept that this is appropriate for delegated legislation simply because the modifications are contingent upon regulations being made under section 3ZA(5) (paragraph 56 of the memorandum). If a bill were introduced containing this provision, we would need to be convinced as to why the modifications should not be set out in the bill itself, even if they would need to be expressed to have effect contingent upon regulations being made under section 3ZA(5).

Fees—clauses 35, 68 and 69

12.  The draft bill confers a power direct on RATE to charge fees and does not confer power on a Minister to prescribe what the Authority may charge (paragraph 58 of the memorandum). Under new section 35B(2) of the 1990 Act (inserted by clause 35) the Secretary of State and the Treasury have an element of control: they must each approve RATE's charging scheme; but there is no Parliamentary control. (Neither is there any Parliamentary control over the fees of the HFEA at present.) What the draft bill proposes is not inappropriate as a matter of delegation but there are other models available as a matter of policy. For example, a common alternative model is for the Secretary of State to prescribe by regulations what the public authority may charge; and those regulations are often subject to a parliamentary procedure. The same applies to clause 68 (licences under the 2004 Act).

13.  Clause 69 enlarges the powers conferred on a Minister of the Crown to make subordinate legislation under section 2(2) of the European Communities Act 1972, as explained at paragraph 66 of the memorandum. Though the extension is modest in its scope (being limited to implementation of the Directives referred to in clause 2), we would require the fullest justification for the need for this provision if this were an actual bill. For example, the department would need to explain what limitation in the 1972 Act prevents the implementing legislation from authorising fees, so far as the Directives require, authorise or do not prevent charging fees; and why this case justifies overriding any such limitation.

Embryo testing and sex selection—Schedule 2, paragraph 3

14.  Paragraph 3 of Schedule 2 to the bill alters the list of activities which may be licensed under the 1990 Act. It inserts new paragraphs 1ZA and 1ZB of Schedule 2 to the 1990 Act, which deal with embryo testing and sex selection respectively. This is explained at paragraphs 63 to 69 of the Explanatory Notes and paragraphs 70 to 72 of the memorandum. New paragraph 1ZC enables the Secretary of State, by regulations subject to affirmative procedure, to amend paragraph 1ZA and make consequential amendments to paragraph 1ZB. Paragraph 1ZC(3) restricts the power so that it cannot be used to enable the authorisation of embryo testing etc. to establish sex except on grounds relating to the health of the resulting child.

15.  Paragraph 71 of the memorandum explains that the power will enable testing for new purposes that may be developed in the future to be regulated. The power may be used to add to, or remove from, the list of permitted purposes or alter the restrictions in paragraph 1ZA(2) to (5). This power is not inappropriately wide in principle but, if there are any particular ways in which Parliament would not wish the power to be exercisable, those ways should be specified in the bill, in addition to the restriction about sex selection on non-health grounds.

LORD SHAW OF NORTHSTEAD

13 June 2007


 
previous page contents next page

House of Lords home page Parliament home page House of Commons home page search page enquiries index

© Parliamentary copyright 2007
Prepared 1 August 2007